PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1477294
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1477294
The syringe market is estimated to be valued at USD 21.98 Bn in 2024 and is expected to reach USD 41.06 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 21.98 Bn |
Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
Forecast Period 2024 to 2031 CAGR: | 9.30% | 2031 Value Projection: | US$ 41.06 Bn |
The global syringe market has been witnessing steady growth over the past few decades. A syringe is an essential accessory used for injecting or extracting fluids from the human body. It consists of a hollow needle attached to a cylindrical tube and plunger within a barrel. Syringes find widespread application for delivering medications such as vaccines, insulin, and others during medical procedures. Changing demographics with rising aging population susceptible to chronic diseases like diabetes have significantly boosted the demand for syringes. Moreover, the growing prevalence of infectious diseases coupled with increasing immunization programs across the globe acts as a key growth driver for the market. However, stringent regulations concerning the reuse and disposal of syringes pose a challenge to market players. Ongoing technological innovations aimed at developing more user-friendly and cost-effective syringes are expected to provide new opportunities for market expansion in the coming years.
The global syringe market is primarily driven by rising incidence of chronic and infectious diseases worldwide which has increased the demand for syringes from the healthcare industry. According to estimates, chronic diseases affect over 143 million Americans annually, accounting for more than 50% of the total healthcare spending in the country. Diabetes, in particular, has emerged as a major public health concern affecting over 30 million people in the U.S. alone. This is expected to significantly boost the demand for insulin syringes. Furthermore, growing emphasis on immunization and vaccination programs by governments and healthcare agencies across both developed and developing nations is favoring the market growth. However, stringent regulations governing the disposal and reuse of syringes acts as a major restraining factor for market players. On the other hand, ongoing R&D to develop more user-friendly and affordable syringes provides new opportunities for market expansion. Syringe manufacturers are designing products with improved ergonomics, safety features, and offerings prefilled with drugs to increase adoption of syringes.
Detailed Segmentation-